Skip to main content
Home » Reports » Healthcare » Cardiac Arrhythmia Monitoring Devices Market
ReesrachMoz Brochure Icon

Global Cardiac Arrhythmia Monitoring Devices Market Analysis and Forecast 2020-2025

Report ID:1464Healthcare235 pages

Cardiac Arrhythmia Monitoring Devices Market Statistics

The global cardiac arrhythmia monitoring devices market is projected to grow at a CAGR of 6.9% and reach the estimated valuation of USD 8.41 bn by 2025, while it accounted for USD 6.02 bn in 2020.

The cardiac arrhythmia monitoring devices market is expected to grow at a strong pace in the coming years. The increasing prevalence of lifestyle diseases and risk factors, technological advancements, and demand for minimally invasive procedures are a few of the factors that are fueling the growth of the cardiac arrhythmia monitoring devices market. Arrhythmias are abnormal heart rhythms that can lead to sudden death if left untreated.

Global Cardiac Arrhythmia Monitoring Devices Market Share By Region Type

New Treatment Modalities to Drive the Cardiac Arrhythmia Monitoring Devices Market

In the treatment line of cardiac arrhythmia, catheter ablation has emerged as a new and crucial modality for patients suffering from various cardiac arrhythmic abnormalities. The new modalities in the treatment include ablation catheters which is designed to break down the targeted tissued with enhanced safety, precision, and robotic help to guide through the electrical mapping, imaging, and accurate catheter movement. These features in the new modalities in the treatment is expected to divert the global cardiac arrhythmia monitoring devices to grow significantly in the coming years.

Minimally Invasive Procedure to Strengthen the Sales of Cardiac Arrhythmia Monitoring Devices

The global cardiac arrhythmia monitoring devices market is driven by the increasing prevalence of lifestyle diseases and risk factors, technological advancements, and demand for minimally invasive procedures. Technological advancements are an important factor driving the growth of the cardiac arrhythmia monitoring devices market. Manufacturers have been investing in new product research and development to introduce more sophisticated products with enhanced functionalities and ease-of-use features. For instance, these manufacturers have been introducing advanced wireless technology for wearable ECGs. Mobile ECGs that can transmit data from anywhere at any time are generating interest among physicians as they help them monitor a patient’s condition from different locations. The advent of wireless technology has also led to a spike in demand for wearable ECGs (electrocardiogram) or mobile ECGs that can transmit data from anywhere at any time directly to doctors or hospitals. Further, lifestyle diseases and risk factors such as hypertension, diabetes mellitus, obesity, high cholesterol levels, smoking, etc., are all associated with increased risks of developing cardiovascular diseases like arrhythmias, thus nudging the increase in the sales of cardiac arrhythmia monitoring devices over the next few years.

However, the side effects and high cost of these devices are expected to act as a restraint in the global cardiac arrhythmia monitoring devices market in the coming years.

Nevertheless, leading healthcare providers and hospital chains have been focusing on establishing specialized arrhythmia centres and monitoring units, which further may bolster the growth opportunities in the cardiac arrhythmia monitoring devices market during the forecast years.

User Friendliness to Strengthen Holter Monitors Segment

Based on product types, the global cardiac arrhythmia monitoring devices market is divided into- Holter monitors, implantable monitors, ECG, and others. But, Holter monitors register the highest revenue in the market, owing to their long duration of use and convenience in monitoring patients. It is user friendly in nature. Further, it is an easy way to monitor the heart function of the patients with no risk involved. It works for outpatients too. It usually can record the heart function for 24 hours or more, thus driving this segment to grow during the forecast period.

In the ECG segment, new technologies are expected to bring out promising results and do wonders. The new wearable technologies rhythm strip generating smart devices and phones by Kardia mobile can record heart functions such as Atrial Fibrillation, Bradycardia, and Tachycardia just in 30 seconds, from anywhere. The emergence of new technologies is estimated to be fruitful for the growth of the global cardiac arrhythmia monitoring devices market. The advent of wireless technology has also led to a spike in demand for wearable ECGs (electrocardiogram) or mobile ECGs that can transmit data from anywhere at any time directly and clinicians can access them as well.

Based on applications, the cardiac arrhythmia monitoring devices market is bifurcated into Atrial Fibrillation, Ventricular Fibrillation, Premature Contraction, Tachycardia, and Bradycardia. However, the Atrial Fibrillation segment is anticipated to dominate the applications segment. The growth can be ascribed to the rising prevalence of the condition. The global number of cases of atrial fibrillation is 37,574 million cases. The cases of atrial fibrillation are foreseen to increase to a larger extent in the coming years.

Based on end-users, the cardiac arrhythmia monitoring devices market is segmented into – Hospitals, Clinics, Diagnostic Centres, and Others. Of all, the hospital and clinics segment are projected to dominate the global cardiac arrhythmic monitoring devices market during the forecast period. The growth in this segment could be accredited to the increasing geriatric population with heart conditions. According to American Heart Association, around 127 million people suffering from heart diseases between 2015 to 2018 and nearly 690,000 lives were lost in 2020 due to heart diseases. These indeed predict the hospital and clinics segment to lead in the coming years.

Increasing Research and Development to Drive North America Market

Based on region, the cardiac arrhythmia monitoring devices market is foretold to be dominated by North America in the global market in the coming years. The growth in the region can be attributed to the research and development,  spending on medical care by the U.S has spiked by 6.4% and reached USD 194.2bn.

Alongside, the Asia Pacific is expected to evolve as the fastest-growing market during the forecast period. The growth in the region can be due to the increasing geriatric population and lifestyle diseases leading to heart conditions. Further, the growth can also be attributed to growing medical tourism and the advent of new technologies in the form of smart wearables that can keep a check on heart conditions.

Competitive Landscape

The global cardiac arrhythmia monitoring devices market is fragmented and highly competitive due to the presence of major players in the market. Moreover, manufacturers are focused on introducing new products with enhanced functionalities and ease-of-use features to target geriatric population for smooth monitoring.

Recent Developments

In March 2022, BIOTRONIK introduced an app for cardiac patients with a device where their heart functioning can be maintained through a mobile app and the clinicians can monitor their progress. This brings in better patient and doctor engagement, right from the comfort of home or remote facility.

In Feb 2022, Abbott received FDA approval for its CARDIOMEMS™ HF SYSTEM which is a small implantable sensor that flags early signs of heart failure and protects patients from falling into the worst situation. The system can let the clinicians know the patient’s condition much earlier and prevent mortality.

Due to the increase in cardiac patients GE Healthcare has announced its collaboration with Medtronics, in April 2022. The collaboration will offer ambulatory surgery services to the patients with excellent services and cost-effective technology solutions to the patients.

Resonate, a cardiac resynchronization therapy defibrillator and cardioverter-defibrillator system for the treatment of cardiac failure was approved by the FDA in 2017.

The major players in the global cardiac arrhythmia monitoring devices market are as follows-

  • Spacelabs Healthcare
  • K.uda Denshi Co., Ltd
  • Medi-Lynx
  • Jude Medical (Abbott)
  • Medtronic
  • Nihon Kohden Corporation
  • Nuubo
  • BioTelemetry, Inc
  • Applied Cardiac Systems
  • AliveCor, Inc.

Type Outlook (Revenue, USD Billion)

  • ECG
  • Holter Monitors
  • Mobile Cardiac Telemetry
  • Implantable Monitors

Application Outlook (Revenue, USD Billion)

  • Tachycardia
  • Bradycardia
  • Atrial Fibrillation
  • Ventricular Fibrillation
  • Premature Contraction
  • Others

End-use Outlook (Revenue, USD Billion)

  • Hospitals & Clinics
  • Diagnostic Centres
  • Others

Regional Outlook

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Greece
  • The Netherlands

Asia Pacific

  • Japan
  • China
  • India

Latin America

  • Mexico
  • Brazil
  • Argentina

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Frequently Asked Questions

What are the growth drivers in the global cardiac Arrhythmia monitoring devices market?

The increasing prevalence of lifestyle diseases and risk factors

What are the barriers to growth?

High cost of the devices may impede the market over the forecast years.

Which sector will control the market under product types?

Holter Monitors will dominate the global cardiac Arrhythmia monitoring devices market over the forecast period.

Which region will lead the global market during the forecast years?

North America will lead the global market owing to high prevalence of heart diseases

Table Of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics

4. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis

5. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Type Outlook
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type Outlook, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type Outlook, 2022-2032
5.3.1. ECG
5.3.2. Holter Monitors
5.3.3. Mobile Cardiac Telemetry
5.3.4. Implantable Monitors
5.4. Y-o-Y Growth Trend Analysis By Type Outlook, 2017-2021
5.5. Absolute $ Opportunity Analysis By Type Outlook, 2022-2032

6. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Application Outlook
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application Outlook, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application Outlook, 2022-2032
6.3.1. Tachycardia
6.3.2. Bradycardia
6.3.3. Atrial Fibrillation
6.3.4. Ventricular Fibrillation
6.3.5. Premature Contraction
6.3.6. Others
6.4. Y-o-Y Growth Trend Analysis By Application Outlook, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application Outlook, 2022-2032

7. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By End-use Outlook
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End-use Outlook, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End-use Outlook, 2022-2032
7.3.1. Hospitals & Clinics
7.3.2. Diagnostic Centres
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By End-use Outlook, 2017-2021
7.5. Absolute $ Opportunity Analysis By End-use Outlook, 2022-2032

8. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region

9. North America Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Type Outlook
9.2.3. By Application Outlook
9.2.4. By End-use Outlook
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type Outlook
9.3.3. By Application Outlook
9.3.4. By End-use Outlook
9.4. Key Takeaways

10. Latin America Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Chile
10.2.1.5. Peru
10.2.1.6. Rest of Latin America
10.2.2. By Type Outlook
10.2.3. By Application Outlook
10.2.4. By End-use Outlook
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type Outlook
10.3.3. By Application Outlook
10.3.4. By End-use Outlook
10.4. Key Takeaways

11. Europe Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Type Outlook
11.2.3. By Application Outlook
11.2.4. By End-use Outlook
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type Outlook
11.3.3. By Application Outlook
11.3.4. By End-use Outlook
11.4. Key Takeaways

12. East Asia Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Type Outlook
12.2.3. By Application Outlook
12.2.4. By End-use Outlook
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type Outlook
12.3.3. By Application Outlook
12.3.4. By End-use Outlook
12.4. Key Takeaways

13. South Asia Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Type Outlook
13.2.3. By Application Outlook
13.2.4. By End-use Outlook
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type Outlook
13.3.3. By Application Outlook
13.3.4. By End-use Outlook
13.4. Key Takeaways

14. Oceania Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Type Outlook
14.2.3. By Application Outlook
14.2.4. By End-use Outlook
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type Outlook
14.3.3. By Application Outlook
14.3.4. By End-use Outlook
14.4. Key Takeaways

15. MEA Cardiac Arrhythmia Monitoring Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Type Outlook
15.2.3. By Application Outlook
15.2.4. By End-use Outlook
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type Outlook
15.3.3. By Application Outlook
15.3.4. By End-use Outlook
15.4. Key Takeaways

16. Key Countries Cardiac Arrhythmia Monitoring Devices Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Type Outlook
16.1.2.2. By Application Outlook
16.1.2.3. By End-use Outlook
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Type Outlook
16.2.2.2. By Application Outlook
16.2.2.3. By End-use Outlook
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Type Outlook
16.3.2.2. By Application Outlook
16.3.2.3. By End-use Outlook
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Type Outlook
16.4.2.2. By Application Outlook
16.4.2.3. By End-use Outlook
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Type Outlook
16.5.2.2. By Application Outlook
16.5.2.3. By End-use Outlook

17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1.  By Regional
17.3.2.  By Type Outlook
17.3.3.  By Application Outlook
17.3.4.  By End-use Outlook

18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Spacelabs Healthcare
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. FU.K.uda Denshi Co., Ltd
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Medi-Lynx
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. St. Jude Medical (Abbott)
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Medtronic
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Nihon Kohden Corporation
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Nuubo
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. BioTelemetry, Inc
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Applied Cardiac Systems
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. AliveCor, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Request Free Sample

Hidden
Hidden

Company logos Strips